Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NFY

The Structure of Human Bisphosphoglycerate Mutase to 1.94A

Summary for 3NFY
Entry DOI10.2210/pdb3nfy/pdb
DescriptorBisphosphoglycerate mutase (2 entities in total)
Functional Keywordshomodimer, synthase, phosphatase, mutase, isomerase
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight62236.75
Authors
Patterson, A.F.,Price, N.C.,Nairn, J. (deposition date: 2010-06-10, release date: 2010-11-10, Last modification date: 2023-09-06)
Primary citationPatterson, A.,Price, N.C.,Nairn, J.
Unliganded structure of human bisphosphoglycerate mutase reveals side-chain movements induced by ligand binding.
Acta Crystallogr.,Sect.F, 66:1415-1420, 2010
Cited by
PubMed Abstract: Erythrocyte-specific bisphosphoglycerate mutase is a trifunctional enzyme which modulates the levels of 2,3-bisphosphoglycerate (2,3-BPG) in red blood cells by virtue of its synthase and phosphatase activities. Low levels of erythrocyte 2,3-BPG increase the affinity of haemoglobin for oxygen, thus limiting the release of oxygen into tissues. 2,3-BPG levels in stored blood decline rapidly owing to the phosphatase activity of bisphosphoglycerate mutase, which is enhanced by a fall in pH. Here, the 1.94 Å resolution X-ray structure of bisphosphoglycerate mutase is presented, focusing on the dynamic nature of key ligand-binding residues and their interaction with the inhibitor citrate. Residues at the binding pocket are complete. In addition, the movement of key residues in the presence and absence of ligand is described and alternative conformations are explored. The conformation in which the ligand citrate would bind at the substrate-binding pocket is proposed, with discussion and representations of its orientation. The characterization of bisphosphoglycerate mutase-citrate interactions will provide a framework for the design of specific inhibitors of the phosphatase activity of this enzyme, which may limit the decline of 2,3-BPG in stored blood.
PubMed: 21045285
DOI: 10.1107/S1744309110035475
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.94 Å)
Structure validation

239492

건을2025-07-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon